News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Aegerion Pharmaceuticals, Inc. Announces Participation at Canaccord Genuity Growth Conference



8/7/2012 9:31:52 AM

CAMBRIDGE, Mass., Aug. 7, 2012 (GLOBE NEWSWIRE) -- Aegerion Pharmaceuticals, Inc. (Nasdaq:AEGR), an emerging biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat debilitating and often fatal rare diseases, announced today that the company will participate in the Canaccord Genuity Growth Conference in Boston. Marc Beer, CEO of Aegerion, is scheduled to present on Tuesday, August 14 at 1:30 pm ET.

Read at GlobeNewswire


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES